Search research articles
Contact Us
Filters
Showing results (301-310 of 316) with videos related to
Page
of 32
Sort By:
The Journal of Allergy and Clinical Immunology
|
November 28, 2015
RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease
Jelle de Wit, M Hussein Al-Mossawi, Michael H Hühn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2020
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism
Ahmed Al-Qassabi, Tsu-Shuen Tsao, Adriana Racolta, et al.
Nature Communications
|
December 8, 2015
Identification of an allosteric binding site for RORγt inhibition
Marcel Scheepstra, Seppe Leysen, Geert C van Almen, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2020
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors
Qinglin Pu, Hongjun Zhang, Liangqin Guo, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors
Derun Li, Hongjun Zhang, Thomas W Lyons, et al.
ACS Medicinal Chemistry Letters
|
September 16, 2021
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology
Min Lu, Hongjun Zhang, Derun Li, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy
Matthew J Mitcheltree, Derun Li, Abdelghani Achab, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy
Hongjun Zhang, Kun Liu, Qinglin Pu, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of <i>N</i>-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases
Hongjun Zhang, Blair T Lapointe, Neville Anthony, et al.
Cell Reports
|
December 24, 2016
Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity
Yanxia Guo, Kenzie D MacIsaac, Yi Chen, et al.
Page
of 32
Search research articles
Search
Showing results (301-310 of 316) with videos related to
Sort By:
Page
of 32
The Journal of Allergy and Clinical Immunology
|
November 28, 2015
RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease
Jelle de Wit, M Hussein Al-Mossawi, Michael H Hühn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 24, 2020
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism
Ahmed Al-Qassabi, Tsu-Shuen Tsao, Adriana Racolta, et al.
Nature Communications
|
December 8, 2015
Identification of an allosteric binding site for RORγt inhibition
Marcel Scheepstra, Seppe Leysen, Geert C van Almen, et al.
ACS Medicinal Chemistry Letters
|
August 25, 2020
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors
Qinglin Pu, Hongjun Zhang, Liangqin Guo, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors
Derun Li, Hongjun Zhang, Thomas W Lyons, et al.
ACS Medicinal Chemistry Letters
|
September 16, 2021
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology
Min Lu, Hongjun Zhang, Derun Li, et al.
ACS Medicinal Chemistry Letters
|
April 16, 2020
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer Immunotherapy
Matthew J Mitcheltree, Derun Li, Abdelghani Achab, et al.
ACS Medicinal Chemistry Letters
|
November 22, 2019
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy
Hongjun Zhang, Kun Liu, Qinglin Pu, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of <i>N</i>-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases
Hongjun Zhang, Blair T Lapointe, Neville Anthony, et al.
Cell Reports
|
December 24, 2016
Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity
Yanxia Guo, Kenzie D MacIsaac, Yi Chen, et al.
Page
of 32